chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In August, my autoimmune stuff flared. So suddenly I was having more joint pain and stiffness than usual. My pancreas was inflamed via CT scan. That was within the first 2 weeks of the vaccine. Starting the 1st week of September, I developed a nasty cough. And it was thought that I had bronchitis and a sinus infection. And it would clear up then come back several times. And I tested negative for COVID twice on those weeks. And I was on steroids which seemed to help. Then on October 25 I had a migraine and I went to the hospital and my O2 was in the 60s and they said my lungs looked bad. They ran bunch of tests and tested negative for everything and I seemed to be improving and sent me home. Then the week of the holiday, I plateaued, I got sick again, rather it came back. I noticed that even pushing the oxygen, I couldn't maintain over 90. I went back to the hospital. They did a CT scan for my 2nd time around, and my lungs looked worse than they did in October. And it really hurt to breathe. They ran panels for everything, and everything came back negative. They did a CT with contrast two days later despite of the allergy and medicated me. They were looking for blood clots in the lungs and they didn't find any. But my lungs got worse in the two days I was in the hospital. So they took me off the antibiotics and put me on high dose steroids and they worked. And they realized it was inflammation related. They sent me home with high dose steroids and step-down instructions and oxygen. I followed the instructions and managed to stay out of the hospital for December. 2 weeks from tomorrow, I noticed that I was dropping into the low 80s just going to the bathroom. So I reached out to my doctors and no body got back to me. Wednesday morning, I went to the ER because it was early comparatively, and they only kept me 5 days instead of 7 days. I'm still struggling to maintain 90 on o2 and during the night as well. All they know is that it is inflammation, and it responds well to steroids. Timing wise, they took me off the Taltz initially, then took me off the 2nd trip. After the 3rd trip, they are taking me off the Belsomra and they seem to be shooting in the dark. Just the timing and they can't rule one way or the other. But the vaccine is still on the list of possible causes. Hospitalization: 1 week in October; 1 week in November; 5 days in January.
Pain and swelling at the site. + erythema. Temp 103. Advised to take tylenol and apply ice  to the site. Fever subsided and symptoms improved over a couple of hours.
Started have very aggressive menstrual cramping. The next day on Sept 16th I started bleeding very heavily and passing menstrual clots. I am exclusively breastfeeding and have not had a menstrual cycle since delivering my baby on April 6, 2021. When I do have a menstrual cycle, it is very mild with no cramping.
The day after the vaccine, I was suffering from severe fatigue.  I developed a runny nose and cough over the next few days.  The cough lasted a week, so I went to the doctor, and they diagnosed me with bronchitis and said it had nothing to the do with the vaccine.  They prescribed a steroid and antibiotic.
Inconsolable crying off and on all day, very irritable. Per urgent care doc, sdoc site of injection may be sore, use Tylenol.
Within 1/2 hour of being vaccinated developed redness, soreness, swollen, and pain ful site of injection
A report was received from a health care professional on 10/22/2003 concerning a 22 month old female vaccinee who inadvertently received Fluvirin on 10/15/2003. The vaccinee did not exhibit any signs or symptoms of an adverse reaction at the time of the report. There was insufficent information to determine the reporter's Causality assessment. Update 1, 11/27/2003: Follow up information was received from a health care professional on 11/27/2003 indicating that the vaccinee was 10 months old. No sequela was noted at the time of the report. No follow up pending. Cross reference with PJP-2003-00913.
Soreness at the site. Extreme sore throat. Exhaustion. Sleeplessness. Very vivid dreams.
Dizzy for 3 days, Numb Tongue for 3 days, Sore Arm for 7 days, Trouble walking for 5 days, Nausea for 3 days, shortness of breath for 3 days, cramps for 2 days, and feeling very tired for 5 days.
Narrative:  RECEIVED VACCINE AT 10:13 AM 9-16-2021. REPORTED TO ER AT 11:31 AM 9-16-21 WITH LEFT JAW STIFFNESS AND SWELLING, TONGUE TINGLING AND DIFFICULTY SWALLOWING
Mom states pt has a red knot where injection was given. No adverse reaction. Pt was given adult pneumococcal vaccination on 03/30/2005.
CHILLS; FEVER; FATIGUE; This spontaneous report received from a consumer concerned a 39 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 03-APR-2021, the subject experienced chills. On 03-APR-2021, the subject experienced fever. On 03-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, and fatigue. This report was non-serious.
Initial report received from healthcare professional on 30 April 2013.  A 26-year-old female patient had received an intramuscular dose of Tdap vaccine (Mfr unknown) (batch number-64612AA, anatomical site of administration was not reported) on an unspecified date. The patient was pregnant. The patient's last menstrual period was on 20 September 2013. The patient's estimated date of delivery was 06 July 2013. The patent's health during pregnancy, risk factors, medical history and concomitant medication was not reported. Laboratory investigations were not reported. As of 30 April 2013, the patient had not experienced any adverse events. Documents held by sender: none.
Pt developed hives on site of injection (left deltoid) gradually covering the whole arm and hand associated with itching and hives appeared less than one hour after injection, at the hospital. When pt came back to clinic but reaction site still active. Advised to take BENADRYL.
Lymphadenopathy, pain right eye, increased temp of 101 ER visit (WNL) ADVIL
Patient had first dose on 4/1/21 he developed fatigue and muscle cramps lasting about 36 hours  Patient had second dose 4/22/21 and once again developed muscle cramps. He also started to have vision changes, increase thirst, and blood sugar spikes between 400-500. He is not a diabetic
Case number PHEH2012US015768 is an initial spontaneous report received from a nurse on 06 Aug 2012. This case refers to an 11-year-old female patient. On 06 Aug 2012, she was vaccinated intramuscularly only with MenA lyophilized conjugate component of MENVEO (batch number: A11051) reconstituted with a sterile water; she did not receive the MenCYW-135 liquid conjugate vaccine component of MENVEO. No adverse event has occurred following maladministration error.
Describing a taste test for a female adult who still does not have taste after covid (not sure if was vaccinated prior or with what vaccine); Describing a taste test for a female adult who still does not have taste after covid (not sure if was vaccinated prior or with what vaccine); This is a spontaneous report received from a contactable reporter (Consumer).  An adult female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome unknown. The patient underwent the following laboratory tests and procedures investigation unknown results, for a female adult who still does not have taste after covid. Drinking different items like soda and alcoholic drinks and condiments. The lot number for bnt162b2 was not provided and will be requested during follow up.
Child (2 mo) admin. expired dose ROTATEQ on 12-17-10 per order from Dr. parent to be called for redose of child - 4 weeks from previous dose on or after 1-17-11.
The injection site was painful for a couple of days and I had a red splotchy rash on my chest and neck the day after the vaccination
Fatigue, Muscle or body aches, Headache, New loss of taste or smell, Congestion or running nose.
The injection was administered in the left arm at the top of my shoulder and I felt a running of "water" inside my arm immediately.    I then tried to do regular activities in the evening and had to stop making supper due to pain in the left upper arm. Used heat, ice and ibuprofen until 10/18/19 when the pain had me in tears for several days in a row. Went to a walk in clinic and was then told to report to HR because this was a flu shot administered at work for the hospital.  I had lost range of motion in the left arm and pain was above a 5 on most days.  I could not sleep though the night and dressing myself became an issue. Sent to a orthopedic doctor on 11/14/19 for a cortisone shot.  That did not help with 90% of the pain, sent for an MRI on  12/12/2019 and results showed a 50% tear.  Did OT for 6 weeks  and was then sent to a surgeon.  Scope surgery on 2/19/2020 removed scar tissue and bursa sac and shaved down the bone.  Currently in physical therapy.
a very sore arm; brain fog/just didn't feel sharp, mentally; had a strange pressure in my head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a very sore arm), FEELING ABNORMAL (brain fog/just didn't feel sharp, mentally) and HEAD DISCOMFORT (had a strange pressure in my head) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (a very sore arm), FEELING ABNORMAL (brain fog/just didn't feel sharp, mentally) and HEAD DISCOMFORT (had a strange pressure in my head). At the time of the report, PAIN IN EXTREMITY (a very sore arm), FEELING ABNORMAL (brain fog/just didn't feel sharp, mentally) and HEAD DISCOMFORT (had a strange pressure in my head) outcome was unknown.            No Concomitant medication details were provided. No Treatment medication details were provided.   This case was linked to MOD-2021-407181, MOD-2021-407223 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Dec-2021: Follow-up received 09-Nov-2021 and does not contain any new information.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID 19 INFECTION; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported 1 total administered for prophylactic vaccination. Vaccination site was not reported. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported.  On an unspecified date, patient experienced suspected covid 19 infection and suspected clinical vaccination failure after receiving Janssen COVID-19 vaccine. Laboratory data (dates unspecified) included: COVID-19 virus test positive (NR: not provided) as Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected covid 19 infection and suspected clinical vaccination failure was not reported. The product quality complaint number was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210422101, 20210423002 and 2021042305; Sender's Comments: 20210436442-covid-19 vaccine ad26.cov2.s -Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
fainting; shivering; nausea; vomiting; This case was reported by a pharmacist via call center representative and described the occurrence of fainting in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd April 2019, the patient received the 1st dose of Shingrix (intramuscular). On 23rd April 2019, immediately after receiving Shingrix, the patient experienced fainting (serious criteria GSK medically significant), shivering, nausea and vomiting. On an unknown date, the outcome of the fainting, shivering, nausea and vomiting were recovered/resolved.   It was unknown if the reporter considered the fainting, shivering, nausea and vomiting to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient came in the pharmacy requesting for the 2nd dose of Shingrix and reported that shortly after 1st dose she experienced shivering, fainting, nausea and vomiting. The reporter consented for follow up.
pt recvd vax & devel redness, swelling & warmth in the arm of inject
This spontaneous case reported by a consumer, describes the occurrence of herpes zoster (shingles) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 040B21A) for COVID-19 immunization. No medical history reported. On Apr 12, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On Apr 16, 2021, patient experienced herpes zoster (shingles). The patient treated with valacyclovir for shingles; 1 dosage form. At the time of the report, herpes zoster (shingles) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or concomitant medications.
CHEST PAIN SHORTNESS OF BREATH Shortness of breath  Pneumonia  Elevated troponin Elevated CK Acute chest pain  Elevated lactic acid level Pneumonia of both lungs due to infectious organism, unspecified part of lung Ground glass opacity present on imaging of lung  Leukocytosis, unspecified type Hematuria, unspecified type Sepsis
Around May, I started to have tingling in my face. I left it alone for about three weeks. I finally contacted my doctor and they wanted to rule out a stroke. I had an MRI and MRA and consults with neurologists, but everything came back negative. There was no other rhyme or reason as to why this happened. After all of the specialty tests were negative, I went back to my PCP. He talked to me about the management of the symptoms. He put me on a course of antiviral medication. He gave me valacyclovir and I am still taking it as of today. I still have tingling that occurs in my face, but it is less severe. I have an annual check-up in January, and we will see where we are at that point.
Booster dose was incorrectly administered outside the 4-day grace window. 2nd dose occurred 9/23/21 ... Booster dose provided on 2/8/22, less than 5 full months later.
Developed a factor VIII inhibitor; This is a spontaneous report received from a contactable reporter(s) (Nurse).  An 82-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Lot number: FN2908) at the age of 82 years for covid-19 immunisation. The patient's relevant medical history included: "MI with stent" (unspecified if ongoing); "CKD" (unspecified if ongoing); "gout" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "MI with stent" (unspecified if ongoing), notes: MI with stent. Concomitant medication(s) included: ALLOPURINOL; NORVASC; LIPITOR; JARDIANCE; COZAAR; METOPROLOL; OXYBUTIN. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, brand unknown=False, is bivalent=False, lot number=EW0161, lot unknown=False, administrator route=Intramuscular, dose number=1), for Covid-19 immunization; Bnt16b2 (product=Pfizer, Other vaccine same date lot number=EW0172, dose number=2), for Covid-19 immunization; Bnt16b2 (product=Pfizer, Other vaccine same date lot number=FE3594,  dose number=3), for Covid-19 immunization. The following information was reported: FACTOR VIII INHIBITION (hospitalization, medically significant, life threatening) with onset 08Jul2022, outcome "recovering", described as "Developed a factor VIII inhibitor". The patient was hospitalized for factor viii inhibition (hospitalization duration: 14 day(s)). The event "developed a factor viii inhibitor" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of factor viii inhibition. Clinical course: The patient did not receive any other vaccine in four weeks. The patient did not have COVID prior vaccination. The patient was not tested COVID post vaccination. The patient had none known allergies. Other vaccine same date dose number=4. Adverse event resulted in: [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event)]. Adverse event treatment: FEIBA, DDAVP, Advate, high dose steroids IV.; Sender's Comments: Based on the information provided, a causal relationship between suspect drug BNT162b2 and the reported event Factor VIII inhibition cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sore arm, sore thigh, back ache, fever, chills, fatigue - all  started within 8-15 hours. All ended within 24-36 hours with the exception of the fever. Stomach discomfort was noticed the morning after the shot (7:30??). The fever and stomach issues continued resulting in a visit to the doctor on Tuesday, April 4/20/21 for a CT scan. This revealed minor Acute Diverticulitis for which I am now taking antibiotics to resolve.
MODERNA COVID-19 VACCINE EUA  Approximately 12 minutes in to the patient's 15 minute post vaccination observation period he reported new onset headache. No reported symptoms of anaphylaxis at this time; the patient was alert and oriented x4. The patient was asked to wait for an additional 15 minutes of observation. After 15 more minutes of observation, the patient continued to endorse a headache and fatigue; no additional symptoms present and the patient was alert and oriented x4. We reviewed common side effects which include headache and fatigue as well as signs of anaphylaxis. We made a plan for patient to contact PCP for any changes or concerns or to contact emergency medical services for evidence of anaphylaxis. Client was discharged from the clinic following a second 15 minute observation period with no acute change in status.
FEELS LIKE SOAR BURNING SENSATION ON LOWER BACK; RASH ON LOWER BACK SPREADING; This spontaneous report received from a patient concerned a 63 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 29-MAR-2021 to Right Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 31-MAR-2021, the subject experienced rash on lower back spreading. On 31-MAR-2021, the subject experienced feels like soar burning sensation on lower back. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rash on lower back spreading, and feels like soar burning sensation on lower back. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Patient complained of headache and nausea. Ran a low fever. We noticed some red spots on his face, and shortly after found hives all over his body, especially arms, ankles,  and buttocks. Took him to the ER and they suggested OTC Benadryl. He had a small amount ( was asleep by then) and hives were gone in the morning.
Mom states parents awakened @ 3AM by noise pt was making; pt was hot & having a convuls; was put in cooltub & fever went down; Later same AM pt had another convuls & was hot, temp was high as 104.5;
Patient came for her Annual Well Child Visit. She was due for Meningococcal ACWY vaccine, instead I mistakenly gave her the MenB Trumenba vaccine. Doctor was notified and she called the patient's mother and told her about the administration error that occurred. Mother understood and per provider, she can still get the right MenACWY vaccine, so patient came back into clinic to receive the right vaccine. Patient was feeling fine and did not experience any symptoms.
Upon arrival pt stated her heart was beating up.  Pt states she has previous history,  OSat 100%, HR: 130, BP: 132/90.  Pt states she feels like a panic attack.  Pt calm down, HR 88, OSat 100%
Syncope (1 event),  dizziness when walking has persisted since syncope on 05/28/2021.
Rash and tenderness in the left arm around the injection site began around 4pm on Thursday February 4, 2021. I contacted my PCP Friday evening, spoke with them Saturday. They advised me to continue the Benadryl,  Zyrtec and famotidine  I had already been taking,  and to ice the area every couple of hours. Rash is dissipating but not fully resolved.
The patients blood sugars shot up from 130 to 450 over a period  of one week, went into DKA,was admitted  to ICU. Patient recovered  home and he  has been on Insulin Lantus.
Patient received shot in the right arm... I was giving the flu shot to the mom and other daughter when after I finished patient states that she is not feeling well. She then gets pale and non-coherent and falls back into her mother's arms and goes stiff as a board and non-responsive. She came back shortly after I went to get the pharmacist and an EMT happened to be in the lobby while we were handling it. Patient then almost puked and I asked the mom if she wanted me to call an ambulance and she responded yes. I then waiting in the vaccine room with the patient on the phone until the ambulance arrived.
The next day I was tired and fatigue and was in bed. I had cospentrithis, I was in pain 24/7. I had an MRI and it did show that I had problem between E6 and E7. I had an inflammation.
Swelled up, red, itchy, not sore (entire upper arm swelled up).
On 09/12/2001 Rash on back, 2100 hrs. Itchy all over today 09/18/2001.
Received Prevnar 1 day ago. Now complains of fever, fussiness, lethargy.